Mattias Perjos

Customs duties and currency headwinds affect Getinge as Q4 orders and sales fall

Medical technology company Getinge reports lower order intake and sales in the fourth quarter compared with the same period last year. This comes as profit before tax rose from SEK 911 million to just over SEK 1.2 billion.

US Tariffs Hit Getinge as Stock Dips Despite Profit Boost

Getinge reports better profit than expected in its quarterly report. CEO Mattias Perjos notes that the medical technology company has already been affected by the US tariffs and the stock falls on the Stockholm Stock Exchange.

Strong Report Boost for Getinge